Prevention of SHIV transmission by topical IFN-β treatment

Mucosal Immunology
Ronald S VeazeyMichael M Lederman

Abstract

Understanding vaginal and rectal HIV transmission and protective cellular and molecular mechanisms is critical for designing new prevention strategies, including those required for an effective vaccine. The determinants of protection against HIV infection are, however, poorly understood. Increasing evidence suggest that innate immune defenses may help protect mucosal surfaces from HIV transmission in highly exposed, uninfected subjects. More recent studies suggest that systemically administered type 1 interferon protects against simian immunodeficiency virus infection of macaques. Here we hypothesized that topically applied type 1 interferons might stimulate vaginal innate responses that could protect against HIV transmission. We therefore applied a recombinant human type 1 interferon (IFN-β) to the vagina of rhesus macaques and vaginally challenged them with pathogenic simian/human immunodeficiency virus (SHIV). Vaginal administration of IFN-β resulted in marked local changes in immune cell phenotype, increasing immune activation and HIV co-receptor expression, yet provided significant protection from SHIV acquisition as interferon response genes were also upregulated. These data suggest that protection from vaginal HIV acquis...Continue Reading

References

Sep 1, 1992·Archives of Otolaryngology--head & Neck Surgery·S J SperberF G Hayden
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·S D DerR H Silverman
Feb 13, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·J R SalkowitzM M Lederman
Sep 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Lu TianPeter J Park
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Sep 26, 2007·Immunity·Andreas Pichlmair, Caetano Reis e Sousa
Dec 20, 2007·The Journal of General Virology·Richard E Randall, Stephen Goodbourn
Jan 18, 2008·Nature·Stuart J D NeilPaul D Bieniasz
Nov 29, 2008·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Michael H Malim
Apr 25, 2009·The Journal of Infectious Diseases·Shamman SewramUNKNOWN CAPRISA Acute Infection Study Team
Sep 18, 2009·Nature·David L ThomasMary Carrington
Feb 5, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kenneth W WitwerJanice E Clements
Apr 28, 2010·The Journal of Infectious Diseases·David M AsmuthUNKNOWN AIDS Clinical Trials Group A5192 Team
Jul 14, 2010·Journal of Medical Primatology·James M SmithRon A Otten
Oct 5, 2010·The Journal of Infectious Diseases·Michael M LedermanJames J Goedert
Jul 12, 2011·Nature Immunology·Helder I NakayaBali Pulendran
Mar 7, 2012·Immunology and Cell Biology·David F Tough
Oct 30, 2012·Bioinformatics·Alexander DobinThomas R Gingeras
Feb 2, 2013·Human Molecular Genetics·Jérôme LaneUNKNOWN NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI)
Feb 25, 2014·The Lancet Infectious Diseases·Glenda E GrayUNKNOWN HVTN 503/Phambili study team
Apr 4, 2014·Bioinformatics·Anthony M BolgerBjoern Usadel
Sep 23, 2014·Cytokine & Growth Factor Reviews·Nadine van MontfoortJohn Hiscott
Sep 28, 2014·Bioinformatics·Simon AndersWolfgang Huber

❮ Previous
Next ❯

Citations

Jan 4, 2017·Reviews in Medical Virology·Rachel A BottingAndrew N Harman
Jan 4, 2017·Immunology and Cell Biology·Albert Garcia-MinambresJohnson Mak
Feb 17, 2017·PLoS Pathogens·Jason A NeidlemanNadia R Roan
Jan 26, 2017·Mucosal Immunology·Mara BiasinMario Clerici
Jan 25, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Paul F McKayRobin J Shattock
Jul 13, 2018·AIDS Research and Human Retroviruses·Sho SugawaraAshwin Balagopal
Aug 5, 2018·American Journal of Reproductive Immunology : AJRI·Steven E BosingerSundaram A Vishwanathan
Feb 15, 2019·Virologica Sinica·Krystelle Nganou-Makamdop, Daniel C Douek
Feb 6, 2020·The Journal of Clinical Investigation·Julie L MitchellUNKNOWN RV397, RV411, and RV254 Study Groups
Mar 25, 2017·Retrovirology·Samuel Mundia KariukiJeffrey R Dorfman
Oct 17, 2017·Frontiers in Immunology·Susanne Maria Ziegler, Marcus Altfeld
Jun 4, 2019·Frontiers in Immunology·Jake William RhodesStuart Grant Turville
Jan 11, 2017·Proceedings of the National Academy of Sciences of the United States of America·Shilpa S IyerBeatrice H Hahn
Oct 17, 2019·Frontiers in Immunology·Kirstie Melissa BertramAndrew Nicholas Harman
Dec 5, 2019·Tropical Diseases, Travel Medicine and Vaccines·Sergey YegorovRupert Kaul
Dec 15, 2018·Journal of Leukocyte Biology·Helen E Cumming, Nollaig M Bourke
Aug 28, 2019·Current Immunology Reviews·Pamela A Kozlowski, Anna Aldovini
May 18, 2020·Trends in Microbiology·Riti SharanDeepak Kaushal

❮ Previous
Next ❯

Methods Mentioned

BETA
RNA-Seq
RNA Seq
biopsy
biopsies
flow cytometry

Software Mentioned

BLAST
STAR aligner
HistoQuest
Deltavision SoftWorX
edgeR
Trimmomatic
Flow jo
TissueGnostics

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.